|
1
|
Bailey JM: The consequences for amino acid
homochirality if L-ribose RNA and not D-ribose RNA had evolved
first. Biochem Soc Trans. 25(S651)1997.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ban J, Shabbir S, Lim M, Lee B and Rhee H:
Synthesis of l-ribose from d-ribose by a stereoconversion through
sequential lactonization as the key transformation. Synthesis.
49:4299–4302. 2017.
|
|
3
|
Chen B, Jamieson ER and Tullius TD: A
general synthesis of specifically deuterated nucleotides for
studies of DNA and RNA. Bioorg Med Chem Lett. 4:3093–3096.
2002.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Illangasekare M, Turk R, Peterson GC,
Lladser M and Yarus M: Chiral histidine selection by D-ribose RNA.
RNA. 16:2370–2383. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Huisman TH, Martis EA and Dozy A:
Chromatography of hemoglobin types on carboxymethylcellulose. J Lab
Clin Med. 52:312–327. 1958.PubMed/NCBI
|
|
6
|
Steinberg T, Poucher RL, Sarin RK, Rees RB
and Gwinup G: Oral administration of D-ribose in diabetes mellitus.
Diabetes. 19:11–16. 1970.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pierce JD, Mahoney DE, Hiebert JB,
Thimmesch AR, Diaz FJ, Smith C, Shen Q, Mudaranthakam DP and Clancy
RL: Study protocol, randomized controlled trial: Reducing symptom
burden in patients with heart failure with preserved ejection
fraction using ubiquinol and/or D-ribose. BMC Cardiovasc Disord.
18(57)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
MacCarter D, Vijay N, Washam M, Shecterle
L, Sierminski H and St Cyr JA: D-ribose aids advanced ischemic
heart failure patients. Int J Cardiol. 137:79–80. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bayram M, St Cyr JA and Abraham WT:
D-ribose aids heart failure patients with preserved ejection
fraction and diastolic dysfunction: A pilot study. Ther Adv
Cardiovasc Dis. 9:56–65. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bao-Hui Y, Qi D, Gui-Qin L and Zheng-Ping
W: The physiological function of D-ribose and its application. Inst
Biopharm Res. 210–212. 2016.
|
|
11
|
zur Nedden S, Doney AS and Frenguelli BG:
Modulation of intracellular ATP determines adenosine release and
functional outcome in response to metabolic stress in rat
hippocampal slices and cerebellar granule cells. J Neurochem.
128:111–124. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pauly DF and Pepine CJ: D-Ribose as a
supplement for cardiac energy metabolism. J Cardiovasc Pharmacol
Ther. 5:249–258. 2000.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Addis P, Shecterle LM and St Cyr JA:
Cellular protection during oxidative stress: A potential role for
D-ribose and antioxidants. J Diet Suppl. 9:178–182. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Busca A and Parra-Herran C: The role of
pathologic evaluation of endometrial ablation resections in
predicting ablation failure and adenomyosis in hysterectomy. Pathol
Res Pract. 212:778–782. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nakamura K, Nakayama K, Ishikawa M,
Katagiri H, Katagiri A, Ishibashi T, Sato E, Asakawa Y and Kyo S:
Efficacy of multiple microwave endometrial ablation technique for
menorrhagia resulting from adenomyosis. J Obstet Gynaecol Res.
41:1769–1772. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Conway VD, Race BA and Chigrinskiy EA:
Role of ribose deficit in rat testicular metabolism under
conditions of overtraining. Bull Exp Biol Med. 150:649–651.
2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kreider RB, Melton C, Greenwood M,
Rasmussen C, Lundberg J, Earnest C and Almada A: Effects of oral
D-ribose supplementation on anaerobic capacity and selected
metabolic markers in healthy males. Int J Sport Nutr Exerc Metab.
13:76–86. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Seifert JG, Brumet A and St Cyr JA: The
influence of D-ribose ingestion and fitness level on performance
and recovery. J Int Soc Sports Nutr. 14(47)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wei Y, Han CS, Zhou J, Liu Y, Chen L and
He RQ: D-ribose in glycation and protein aggregation. Biochim
Biophys Acta. 1820:488–494. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Omran H, Illien S, MacCarter D, St Cyr J
and Lüderitz B: D-Ribose improves diastolic function and quality of
life in congestive heart failure patients: A prospective
feasibility study. Eur J Heart Fail. 5:615–619. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shecterle LM, Terry KR and St Cyr JA:
Potential clinical benefits of D-ribose in ischemic cardiovascular
disease. Cureus. 10(e2291)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wallen WJ, Belanger MP and Wittnich C:
Preischemic administration of ribose to delay the onset of
irreversible ischemic injury and improve function: Studies in
normal and hypertrophied hearts. Can J Physiol Pharmacol. 81:40–47.
2003.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Chen X, Su T, Chen Y, He Y, Liu Y, Xu Y,
Wei Y, Li J and He R: d-Ribose as a contributor to glycated
haemoglobin. EBioMedicine. 25:143–153. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yuan BH, Liu GQ, Liu M, Li DC, Han J and
Wang ZP: Study on the anti-fatigue effect of compound D-ribose on
mice. Sci Technol Food Ind. 349–353. 2016.
|
|
25
|
Tsakiris N, Papavasileiou M, Bozzato E,
Lopes A, Vigneron AM and Préat V: Combinational drug-loaded lipid
nanocapsules for the treatment of cancer. Int J Pharm.
569(118588)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Derosa G, Pasqualotto S, Catena G,
D'Angelo A, Maggi A and Maffioli P: A randomized, double-blind,
placebo-controlled study to evaluate the effectiveness of a food
supplement containing creatine and D-ribose combined with a
physical exercise program in increasing stress tolerance in
patients with ischemic heart disease. Nutrients.
11(3075)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jhawar SR, Goyal S, Thandoni A, Wu H,
Hassan S, Schiff DS, Allen J, Stogniew M, Tarapore R, Stein M, et
al: Combination radiation therapy and imipridone ONC201 for the
treatment of solid tumors. Int J Radiat Oncol Biol Phys. 99 (Suppl
2):E598–E599. 2017.
|
|
28
|
Kajiwara H: Motif 2 in adenosine kinase
homologous ginseng polypeptide showed affinity to D-ribose by
capillary zone electrophoresis and surface plasmon resonance. J
Chromatogr A. 817:173–179. 1998.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ataka S, Tanaka M, Nozaki S, Mizuma H,
Mizuno K, Tahara T, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, et
al: Effects of oral administration of caffeine and D-ribose on
mental fatigue. Nutrition. 24:233–238. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yuanbao Hui LQ, Min L, Cheng L, Jun H and
Ping W: Study on anti- fatigue effect of compound D-ribose on mice.
Sci Technol Food Ind. 22:349–353. 2016.
|
|
31
|
Kitamoto T, Sakurai K, Lee EY, Yokote K,
Accili D and Miki T: Distinct roles of systemic and local actions
of insulin on pancreatic β-cells. Metabolism. 82:100–110.
2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Czech MP: Insulin action and resistance in
obesity and type 2 diabetes. Nat Med. 23:804–814. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang Y, Sun S, Jia H, Qi Y, Zhang J, Lin
L, Chen Y, Wang W and Ning G: The optimized calculation method for
insulin dosage in an insulin tolerance test (ITT): A randomized
parallel control study. Front Endocrinol (Lausanne).
11(202)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Petersen MC and Shulman GI: Mechanisms of
insulin action and insulin resistance. Physiol Rev. 98:2133–2223.
2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Adeva-Andany M, Souto-Adeva G,
Ameneiros-Rodríguez E, Fernández-Fernández C, Donapetry-García C
and Domínguez-Montero A: Insulin resistance and glycine metabolism
in humans. Amino Acids. 50:11–27. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hong J, Wang X, Zhang N, Fu H and Li W:
D-ribose induces nephropathy through RAGE-dependent NF-κB
inflammation. Arch Pharm Res. 41:838–847. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Rassaf T and Totzeck M: Modern concepts in
cardio-oncology. J Thorac Dis. 10 (Suppl 35):S4386–S4390.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Williams JW, Huang LH and Randolph GJ:
Cytokine circuits in cardiovascular disease. Immunity. 50:941–954.
2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Shaito A, Thuan DTB, Phu HT, Nguyen THD,
Hasan H, Halabi S, Abdelhady S, Nasrallah GK, Eid AH and Pintus G:
Herbal medicine for cardiovascular diseases: Efficacy, mechanisms,
and safety. Front Pharmacol. 11(422)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
MA LF, Yang SQ and Yang QJ: Protective
effect of exogenous D-ribose on myocardial ischemia/reperfusion
injury of rat hearts. J Chongqing Med Univ. 6:689–692. 2011.(In
Chinese).
|
|
41
|
Sen S and Chakraborty R: Treatment and
diagnosis of diabetes mellitus and its complication: Advanced
approaches. Mini Rev Med Chem. 15:1132–1133. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Nagai R, Murray DB, Metz TO and Baynes JW:
Chelation: A fundamental mechanism of action of AGE inhibitors, AGE
breakers, and other inhibitors of diabetes complications. Diabetes.
61:549–559. 2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Salci MA, Meirelles BHS and Silva DMVGD:
Prevention of chronic complications of diabetes mellitus according
to complexity. Rev Bras Enferm. 70:996–1003. 2017.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
44
|
You Y, Liu F, Gao S, Lin Y and Ge B:
D-ribose Induced Rapid Non-enzymatic Glycation of Human Myoglobin.
J Nanhua Univ. 44499–503. (535)2016.
|
|
45
|
Chehregosha H, Khamseh ME, Malek M,
Hosseinpanah F and Ismail-Beigi F: A view beyond HbA1c: Role of
continuous glucose monitoring. Diabetes Ther. 10:853–863.
2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yap CW, Ang YG, Quek TPL, Heng BH and Chew
DEK: Re-examining the sensitivity of HbA1c to screen for diabetes
mellitus. J Diabetes. 10:380–385. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Siddiqui Z, Faisal M, Alatar AR and Ahmad
S: Prevalence of auto-antibodies against
D-ribose-glycated-hemoglobin in diabetes mellitus. Glycobiology.
29:409–418. 2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Chen Y, Yu L, Wang Y, Wei Y, Xu Y, He T
and He R: d-Ribose contributes to the glycation of serum protein.
Biochim Biophys Acta Mol Basis Dis. 1865:2285–2292. 2019.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yamamoto Y and Yamamoto H: RAGE-mediated
inflammation, type 2 diabetes, and diabetic vascular complication.
Front Endocrinol (Lausanne). 4(105)2013.PubMed/NCBI View Article : Google Scholar
|
|
50
|
brutorum WTDa: An account of some books.
Philos Trans R Soc Lond. 7:4071–4078. 1672.
|
|
51
|
Ekbom KA: Asthenia crurum paraesthetica
(Irritable legs). Acta Med Scand. 118:197–209. 1944.
|
|
52
|
Shecterle L, Kasubick R and Cyr JS:
D-ribose benefits restless legs syndrome. J Altern Complement Med.
14:1165–1166. 2008.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Teitelbaum J, Jandrain J and McGrew R:
Treatment of chronic fatigue syndrome and fibromyalgia with
D-ribose-an open-label, multicenter study. Open Pain J. 5:32–37.
2012.
|
|
54
|
Gebhart B and Jorgenson JA: Benefit of
ribose in a patient with fibromyalgia. Pharmacotherapy.
24:1646–1648. 2004.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Arnaud JP: Cosmetic use of D-ribose and
method thereof. United States Patent Application Publication,
2007.
|
|
56
|
Shecterle LM and St Cyr JA: Dermal
benefits of topical D-ribose. Clin Cosmet Investig Dermatol.
2:151–152. 2009.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Griffiths JC, Borzelleca JF and St Cyr J:
Sub-chronic (13-week) oral toxicity study with D-ribose in Wistar
rats. Food Chem Toxicol. 45:144–152. 2007.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Ismail ZB, Abu-Baker N, Alzoubi K,
Al-Zhgoul M, Al-Essa MK, Khlouf S, Al-Saleh A, Al-Omari B,
Abu-Tayeh R, Shomaf M, et al: Evaluation of α-D-ribofuranose
(D-ribose) toxicity after intravenous administration to rabbits.
Hum Exp Toxicol. 31:820–829. 2012.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Sinatra ST and Caiazzo C: (D)-Ribose
supplementation in the equine: Lack of effect on glycated plasma
proteins suggesting safety in humans. J Am Coll Nutr. 34:108–112.
2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Peppa M, Uribarri J and Vlassara H:
Glucose, advanced glycation end products, and diabetes
complications: What is new and what works. Clin Diabetes.
21:186–187. 2003.
|
|
61
|
Yamamoto Y and Yamamoto H: Receptor for
advanced glycation end-products-mediated inflammation and diabetic
vascular complications. J Diabetes Investig. 2:155–157.
2011.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Yu L, Chen Y, Xu Y, He T, Wei Y and He R:
D-ribose is elevated in T1DM patients and can be involved in the
onset of encephalopathy. Aging (Albany NY). 11:4943–4969.
2019.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Iannuzzi C, Borriello M, Carafa V, Altucci
L, Vitiello M, Balestrieri ML, Ricci G, Irace G and Sirangelo I:
D-ribose-glycation of insulin prevents amyloid aggregation and
produces cytotoxic adducts. Biochim Biophys Acta. 1862:93–104.
2016.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Javed M, Ahmad MI, Javed H and Naseem S:
D-ribose and pathogenesis of Alzheimer's disease. Mol Biol Rep.
47:2289–2299. 2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Han C, Lu Y, Wei Y, Liu Y and He R:
D-ribose induces cellular protein glycation and impairs mouse
spatial cognition. PLoS One. 6(e24623)2011.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Wei Y, Chen L, Chen J, Ge L and He RQ:
Rapid glycation with D-ribose induces globular amyloid-like
aggregations of BSA with high cytotoxicity to SH-SY5Y cells. BMC
Cell Biol. 10(10)2009.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Xu WL, von Strauss E, Qiu CX, Winblad B
and Fratiglioni L: Uncontrolled diabetes increases the risk of
Alzheimer's disease: A population-based cohort study. Diabetologia.
52:1031–1039. 2009.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Chen L, Wei Y, Wang X and He R:
Ribosylation rapidly induces alpha-synuclein to form highly
cytotoxic molten globules of advanced glycation end products. PLoS
One. 5(e9052)2010.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Wei Y, Chen L and He RQ: D-ribosylated tau
forms globular aggregates with high cytotoxicity. Alzheimer's
Dementia. 5(395)2009.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Wu B, Wei Y, Wang Y, Su T, Zhou L, Liu Y
and He R: Gavage of D-Ribose induces Aβ-like deposits, Tau
hyperphosphorylation as well as memory loss and anxiety-like
behavior in mice. Oncotarget. 6:34128–34142. 2015.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Wu B, Wang Y, Shi C, Chen Y, Yu L, Li J,
Li W, Wei Y and He R: Ribosylation-derived advanced glycation end
products induce tau hyperphosphorylation through brain-derived
neurotrophic factor reduction. J Alzheimers Dis. 71:291–305.
2019.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Wang Y, Shi C, Chen Y, Yu L, Li Y, Wei Y,
Li W and He R: Formaldehyde produced from d-ribose under neutral
and alkaline conditions. Toxicol Rep. 6:298–304. 2019.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Han C, Lu Y, Wei Y, Wu B, Liu Y and He R:
D-ribosylation induces cognitive impairment through RAGE-dependent
astrocytic inflammation. Cell Death Dis. 5(e1117)2014.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Gheith O, Farouk N, Nampoory N, Halim MA
and Al-Otaibi T: Diabetic kidney disease: World wide difference of
prevalence and risk factors. J Nephropharmacol. 5:49–56.
2015.PubMed/NCBI
|
|
75
|
Shevalye H, Maksimchyk Y, Watcho P and
Obrosova IG: Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency
alleviates diabetic kidney disease. Biochim Biophys Acta.
1802:1020–1027. 2010.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Shevalye H, Stavniichuk R, Xu W, Zhang J,
Lupachyk S, Maksimchyk Y, Drel VR, Floyd EZ, Slusher B and Obrosova
IG: Poly(ADP-ribose) polymerase (PARP) inhibition counteracts
multiple manifestations of kidney disease in long-term
streptozotocin-diabetic rat model. Biochem Pharmacol. 79:1007–1014.
2010.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Drel VR, Pacher P, Stevens MJ and Obrosova
IG: Aldose reductase inhibition counteracts nitrosative stress and
poly(ADP-ribose) polymerase activation in diabetic rat kidney and
high-glucose-exposed human mesangial cells. Free Radic Biol Med.
40:1454–1465. 2006.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Trevisan R and Dodesini AR: The
hyperfiltering kidney in diabetes. Nephron. 136:277–280.
2017.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Zeni L, Norden AGW, Cancarini G and Unwin
RJ: A more tubulocentric view of diabetic kidney disease. J
Nephrol. 30:701–717. 2017.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Kumar Pasupulati A, Chitra PS and Reddy
GB: Advanced glycation end products mediated cellular and molecular
events in the pathology of diabetic nephropathy. Biomol Concepts.
7:293–309. 2016.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Yuan Y, Sun H and Sun Z: Advanced
glycation end products (AGEs) increase renal lipid accumulation: A
pathogenic factor of diabetic nephropathy (DN). Lipids Health Dis.
16(126)2017.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Yamagishi S and Matsui T: Advanced
glycation end products, oxidative stress and diabetic nephropathy.
Oxid Med Cell Longev. 3:101–108. 2010.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Hou FF, Ren H, Owen WF Jr, Guo ZJ, Chen
PY, Schmidt AM, Miyata T and Zhang X: Enhanced expression of
receptor for advanced glycation end products in chronic kidney
disease. J Am Soc Nephrol. 5:1889–1896. 2004.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Lapolla A, Fedele D, Seraglia R and Traldi
P: The role of mass spectrometry in the study of non-enzymatic
protein glycation in diabetes: An update. Mass Spectrom Rev.
25:775–797. 2006.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Zhang N, Zhao S, Hong J, Li W and Wang X:
Protective effects of kaempferol on D-ribose-induced mesangial cell
injury. Oxid Med Cell Longev. 2019(7564207)2019.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Hong J, Bhat OM, Li G, Dempsey SK, Zhang
Q, Ritter JK, Li W and Li PL: Lysosomal regulation of extracellular
vesicle excretion during d-ribose-induced NLRP3 inflammasome
activation in podocytes. Biochim Biophys Acta Mol Cell Res.
1866:849–860. 2019.PubMed/NCBI View Article : Google Scholar
|
